Similar articles for PMID: 19164225

Year	Number of Results
1932	1
1983	1
1984	1
1987	1
1988	1
1990	1
1993	2
1996	4
1997	6
1998	6
1999	2
2000	2
2001	2
2002	2
2003	5
2004	4
2005	4
2006	14
2007	8
2008	6
2009	24
2010	23
2011	23
2012	21
2013	34
2014	24
2015	25
2016	17
2017	19
2018	16
2019	10
2020	11
2021	13
2022	16
2023	4
2024	1

1

131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.

Spanu A, Solinas ME, Chessa F, Sanna D, Nuvoli S, Madeddu G. Spanu A, et al. J Nucl Med. 2009 Feb;50(2):184-90. doi: 10.2967/jnumed.108.056572. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164225 Free article.

2

Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.

Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, Sandler MP, Delbeke D. Tharp K, et al. Eur J Nucl Med Mol Imaging. 2004 Oct;31(10):1435-42. doi: 10.1007/s00259-004-1565-2. Epub 2004 Jun 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 15221294 Clinical Trial.

3

Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.

Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H, Zhu R. Chen L, et al. J Nucl Med. 2008 Dec;49(12):1952-7. doi: 10.2967/jnumed.108.052399. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997044 Free article.

4

Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a ¹³¹I-SPECT/CT study.

Spanu A, Nuvoli S, Marongiu A, Gelo I, Mele L, Piras B, Madeddu G. Spanu A, et al. BMC Cancer. 2020 Mar 20;20(1):239. doi: 10.1186/s12885-020-06744-1. BMC Cancer. 2020. PMID: 32197595 Free PMC article.

5

Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.

Yamamoto Y, Nishiyama Y, Monden T, Matsumura Y, Satoh K, Ohkawa M. Yamamoto Y, et al. J Nucl Med. 2003 Dec;44(12):1905-10. J Nucl Med. 2003. PMID: 14660715 Free article. Clinical Trial.

6

Scintigraphic TNM staging of tumors: a proposition.

Oommen R. Oommen R. J Nucl Med. 2009 Aug;50(8):1386; author reply 1386. doi: 10.2967/jnumed.109.062745. Epub 2009 Jul 17. J Nucl Med. 2009. PMID: 19617337 Free article. No abstract available.

7

Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.

Barwick T, Murray I, Megadmi H, Drake WM, Plowman PN, Akker SA, Chew SL, Grossman AB, Avril N. Barwick T, et al. Eur J Endocrinol. 2010 Jun;162(6):1131-9. doi: 10.1530/EJE-09-1023. Epub 2010 Mar 8. Eur J Endocrinol. 2010. PMID: 20212015

8

Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.

Wong KK, Sisson JC, Koral KF, Frey KA, Avram AM. Wong KK, et al. AJR Am J Roentgenol. 2010 Sep;195(3):730-6. doi: 10.2214/AJR.09.3458. AJR Am J Roentgenol. 2010. PMID: 20729453

9

Differentiated thyroid carcinoma: Incremental diagnostic value of ¹³¹I SPECT/CT over planar whole body scan after radioiodine therapy.

Zilioli V, Peli A, Panarotto MB, Magri G, Alkraisheh A, Wiefels C, Rodella C, Giubbini R. Zilioli V, et al. Endocrine. 2017 Jun;56(3):551-559. doi: 10.1007/s12020-016-1086-3. Epub 2016 Sep 29. Endocrine. 2017. PMID: 27709475

10

The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.

Grewal RK, Tuttle RM, Fox J, Borkar S, Chou JF, Gonen M, Strauss HW, Larson SM, Schöder H. Grewal RK, et al. J Nucl Med. 2010 Sep;51(9):1361-7. doi: 10.2967/jnumed.110.075960. Epub 2010 Aug 18. J Nucl Med. 2010. PMID: 20720058 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year